Literature DB >> 3767014

The in vitro and in vivo effects of isoflurane and nitrous oxide on platelet aggregation.

B G Fauss, J C Meadows, C Y Bruni, G D Qureshi.   

Abstract

In view of the possible antiaggregation effects of newer general anesthetics we investigated the in vitro and in vivo effects of isoflurane and nitrous oxide on platelet aggregation. Platelets obtained from 18 healthy volunteers, were exposed in vitro for 30 min in a closed chamber to oxygen-carbon dioxide (90%, 5%) (control), oxygen-carbon dioxide-nitrous oxide (80%), or oxygen-carbon dioxide-isoflurane (1.5%) with or without nitrous oxide (80%). Samples were tested in ADP- and collagen-induced aggregation tests. Both nitrous oxide and isoflurane produced statistically significant inhibition of ADP-induced aggregation. Inhibition of collagen-induced aggregation was not statistically significant. In 18 patients who received nitrous oxide (3 L/min) and isoflurane (1-2%) during anesthesia, platelet aggregation was reduced significantly. We conclude that both nitrous oxide and isoflurane cause moderate but statistically significant inhibition of platelet aggregation that may be clinically important in some patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767014

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Effects of isoflurane, sevoflurane, and desflurane on platelet function: A prospective, randomized, single-blind, in vivo study.

Authors:  Nesrin Bozdogan; Halit Madenoglu; Kudret Dogru; Karamehmet Yildiz; Mustafa S Kotanoglu; Mustafa Cetin; Adem Boyaci
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

2.  The effects of desflurane on human platelet aggregation in vitro.

Authors:  Hülya Türkan; Cengiz Beyan; Lale Karabiyik; Derya Güner; Kürşat Kaptan
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

Review 3.  Effect of Inhalation Anesthetics on Tumor Metastasis.

Authors:  Yixin Jing; Yiguo Zhang; Rui Pan; Ke Ding; Rong Chen; Qingtao Meng
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.